William C. Goings - 20 Feb 2026 Form 4 Insider Report for TrueBlue, Inc. (TBI)

Reporting relationship: Director
Issuer ticker: TBI
Reported as of: 20 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Feb 2026, 10:59:06 UTC
Prior SEC filing: 17 Jun 2025
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Todd N. Gilman, Attorney-in-fact

Key filing fact

William C. Goings filed Form 4 for TrueBlue, Inc. (TBI) on 24 Feb 2026.

Key facts

This page summarizes William C. Goings's Form 4 filing for TrueBlue, Inc. (TBI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Feb 2026, 10:59.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001671108 Primary reporting owner

Goings William C.

Relationship: Director
Address: 1015 A STREET, TACOMA
Signature: /s/ Todd N. Gilman, Attorney-in-fact
Signature date: 24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBI transaction

Common Stock

Award

Transaction value: $0
Shares: +29,607
Change %: +53%
Price: $0.000000
Shares after: 85,000
Date: 20 Feb 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors.

Footnote F2

This total includes 85,000 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.